{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:30Z","timestamp":1792785870580,"version":"4.5.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Steno Diabetes Center Odense, University Hospital of Odense, Denmark","id":[{"id":"https:\/\/ror.org\/00ey0ed83","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Food intake stimulates secretion of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which acutely suppress systemic markers of bone resorption in humans. Whether incretins exert parallel effects on bone turnover within the bone marrow (BM) microenvironment during hyperglycaemia is unknown. We investigated the acute effects of GLP-1, GIP, and their combination on bone turnover in BM under hyperglycaemic conditions, alongside BM metabolomics and stromal cell characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Crossover study in healthy men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twelve men completed 3 study days with 2-hour intravenous infusions of GLP-1, GIP, or combined GLP-1 + GIP during a hyperglycaemic clamp targeting postprandial plasma glucose. Bone resorption (C-terminal telopeptide of type I collagen, CTX) and formation (procollagen type I N-terminal propeptide, P1NP) markers were measured in peripheral plasma during infusions and in BM plasma before and after infusions. Untargeted metabolomic profiling by liquid chromatography-mass spectrometry was performed on BM plasma, and BM stromal cells (BMSCs) were assessed ex vivo for clonogenic capacity and osteogenic and adipogenic differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All infusions suppressed BM plasma CTX to a similar extent. P1NP increased transiently in peripheral plasma during GIP and GLP-1 + GIP infusions and was elevated in BM plasma after GIP infusion. Metabolomics revealed changes consistent with altered glucose and insulin levels, without a bone-specific signature. BMSC differentiation was unchanged, although clonogenic capacity was reduced after GLP-1 + GIP infusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Under hyperglycaemic conditions, both incretins acutely suppressed bone resorption in healthy men without detectable bone-specific metabolic signatures. GIP was additionally associated with increased BM P1NP at 2\u2005hours, in contrast to only a short-lived rise in peripheral plasma, suggesting a possible transient uncoupling of bone turnover.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag181","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:25:42Z","timestamp":1789755942000},"page":"549-561","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow responses to GLP-1 and GIP infusion under hyperglycaemic conditions"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-2929","authenticated-orcid":false,"given":"Nina W\u00e6rling","family":"Hansen","sequence":"first","affiliation":[{"name":"Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital , 5000 Odense C ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-8542","authenticated-orcid":false,"given":"Morten Svarer","family":"Hansen","sequence":"additional","affiliation":[{"name":"Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital , 5000 Odense C ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-5431","authenticated-orcid":false,"given":"Jesper","family":"Havelund","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-5287","authenticated-orcid":false,"given":"Nils","family":"F\u00e6rgeman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-2036","authenticated-orcid":false,"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen , 2200 Copenhagen N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]},{"name":"Steno Diabetes Center Odense, University Hospital of Odense , 5260 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Frost","sequence":"additional","affiliation":[{"name":"Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital , 5000 Odense C ,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]},{"name":"Steno Diabetes Center Odense, University Hospital of Odense , 5260 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"6","key":"2026100513374562700_lvag181-B1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"issue":"6","key":"2026100513374562700_lvag181-B2","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"2026100513374562700_lvag181-B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"2026100513374562700_lvag181-B4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"2026100513374562700_lvag181-B5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/edrv-7-4-379","article-title":"Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease","volume":"7","author":"Eriksen","year":"1986","journal-title":"Endocr Rev."},{"issue":"1","key":"2026100513374562700_lvag181-B6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S8756-3282(01)00662-7","article-title":"Mechanism of circadian variation in bone resorption","volume":"30","author":"Bjarnason","year":"2002","journal-title":"Bone"},{"issue":"7","key":"2026100513374562700_lvag181-B7","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1210\/jc.2019-00008","article-title":"Separate and combined effects of GIP and GLP-1 infusions on bone metabolism in overweight men without diabetes","volume":"104","author":"Bergmann","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026100513374562700_lvag181-B8","doi-asserted-by":"publisher","first-page":"e10209","DOI":"10.1002\/jbm4.10209","article-title":"A pilot study showing acute inhibitory effect of GLP-1 on the bone resorption marker CTX in humans","volume":"3","author":"Nissen","year":"2019","journal-title":"JBMR Plus"},{"issue":"1","key":"2026100513374562700_lvag181-B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1210\/jc.2017-01949","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia","volume":"103","author":"Christensen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100513374562700_lvag181-B10","doi-asserted-by":"publisher","first-page":"115553","DOI":"10.1016\/j.bone.2020.115553","article-title":"The role of endogenous GIP and GLP-1 in postprandial bone homeostasis","volume":"140","author":"Helsted","year":"2020","journal-title":"Bone"},{"key":"2026100513374562700_lvag181-B11","doi-asserted-by":"publisher","first-page":"115197","DOI":"10.1016\/j.bone.2019.115197","article-title":"Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial","volume":"132","author":"Hygum","year":"2020","journal-title":"Bone"},{"key":"2026100513374562700_lvag181-B12","doi-asserted-by":"publisher","first-page":"102624","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2026100513374562700_lvag181-B13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/dom.70186","article-title":"Acute effects of GIP and GLP-1 receptor antagonism in totally pancreatectomized individuals: a randomized double-blind, placebo-controlled crossover study","volume":"28","author":"Krogh","year":"2026","journal-title":"Diabetes Obes Metab."},{"key":"2026100513374562700_lvag181-B14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bone.2016.07.014","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption","volume":"91","author":"Mabilleau","year":"2016","journal-title":"Bone"},{"issue":"1","key":"2026100513374562700_lvag181-B15","doi-asserted-by":"publisher","first-page":"lvac004","DOI":"10.1093\/ejendo\/lvac004","article-title":"GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells","volume":"188","author":"Hansen","year":"2023","journal-title":"Eur J Endocrinol."},{"issue":"12","key":"2026100513374562700_lvag181-B16","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1210\/clinem\/dgac542","article-title":"GIP affects hepatic fat and brown adipose tissue thermogenesis but not white adipose tissue transcriptome in type 1 diabetes","volume":"107","author":"Heimb\u00fcrger","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026100513374562700_lvag181-B17","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.celrep.2019.04.066","article-title":"Obesity-associated hypermetabolism and accelerated senescence of bone marrow stromal stem cells suggest a potential mechanism for bone fragility","volume":"27","author":"Tencerova","year":"2019","journal-title":"Cell Rep"},{"key":"2026100513374562700_lvag181-B18","doi-asserted-by":"publisher","first-page":"115252","DOI":"10.1016\/j.bone.2020.115252","article-title":"Resveratrol inhibits adipocyte differentiation and cellular senescence of human bone marrow stromal stem cells","volume":"133","author":"Ali","year":"2020","journal-title":"Bone"},{"issue":"11","key":"2026100513374562700_lvag181-B19","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s13361-017-1748-2","article-title":"Extending a tandem mass spectral library to include MS2 spectra of fragment ions produced in-source and MSn spectra","volume":"28","author":"Yang","year":"2017","journal-title":"J Am Soc Mass Spectrom"},{"issue":"7","key":"2026100513374562700_lvag181-B20","doi-asserted-by":"publisher","first-page":"btae459","DOI":"10.1093\/bioinformatics\/btae459","article-title":"MetaboLink: a web application for streamlined processing and analysis of large-scale untargeted metabolomics data","volume":"40","author":"Mendes","year":"2024","journal-title":"Bioinformatics"},{"issue":"7","key":"2026100513374562700_lvag181-B21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2-3","key":"2026100513374562700_lvag181-B22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0167-0115(03)00111-3","article-title":"Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects","volume":"114","author":"Vilsb\u00f8ll","year":"2003","journal-title":"Regul Pept"},{"issue":"12","key":"2026100513374562700_lvag181-B23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11306-022-01963-y","article-title":"Good practices and recommendations for using and benchmarking computational metabolomics metabolite annotation tools","volume":"18","author":"de Jonge","year":"2022","journal-title":"Metabolomics"},{"issue":"4","key":"2026100513374562700_lvag181-B24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.bbrc.2016.09.116","article-title":"Plasma acylcarnitines during insulin stimulation in humans are reflective of age-related metabolic dysfunction","volume":"479","author":"Consitt","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2026100513374562700_lvag181-B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbapap.2004.07.002","article-title":"Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress","volume":"1702","author":"Anraku","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"2026100513374562700_lvag181-B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcdb.2021.06.024","article-title":"Alliances of the gut and bone axis","volume":"123","author":"Hansen","year":"2022","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"2026100513374562700_lvag181-B27","doi-asserted-by":"publisher","first-page":"E522","DOI":"10.1152\/ajpendo.00086.2025","article-title":"The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice","volume":"329","author":"Mermet","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026100513374562700_lvag181-B28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bone.2017.12.029","article-title":"The relationship between bone turnover and insulin sensitivity and secretion: cross-sectional and prospective data from the RISC cohort study","volume":"108","author":"Frost","year":"2018","journal-title":"Bone"},{"issue":"1","key":"2026100513374562700_lvag181-B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0014-5793(89)81527-3","article-title":"Secretion of islet amyloid polypeptide in response to glucose","volume":"259","author":"Kanatsuka","year":"1989","journal-title":"FEBS Lett"},{"issue":"4","key":"2026100513374562700_lvag181-B30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0196-9781(97)00056-9","article-title":"Effects of amylin on human osteoblast-like cells","volume":"18","author":"Villa","year":"1997","journal-title":"Peptides"},{"issue":"4","key":"2026100513374562700_lvag181-B31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo","volume":"164","author":"Dacquin","year":"2004","journal-title":"J Cell Biol"},{"key":"2026100513374562700_lvag181-B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00125-025-06497-1","article-title":"61st EASD Annual Meeting of the European Association for the Study of Diabetes: Vienna, Austria, 15\u201319 September 2025","volume":"68","year":"2025","journal-title":"Diabetologia"},{"issue":"1","key":"2026100513374562700_lvag181-B33","doi-asserted-by":"publisher","first-page":"E259","DOI":"10.1210\/clinem\/dgad431","article-title":"Signs of a glucose- and insulin-independent gut-bone axis and aberrant bone homeostasis in type 1 diabetes","volume":"109","author":"Hartmann","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026100513374562700_lvag181-B34","doi-asserted-by":"publisher","first-page":"bvaa097","DOI":"10.1210\/jendso\/bvaa097","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) reduces bone resorption in patients with type 2 diabetes","volume":"4","author":"Christensen","year":"2020","journal-title":"J Endocr Soc"},{"key":"2026100513374562700_lvag181-B35","doi-asserted-by":"publisher","first-page":"115079","DOI":"10.1016\/j.bone.2019.115079","article-title":"GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3\u201330)NH2","volume":"130","author":"Gasbjerg","year":"2020","journal-title":"Bone"},{"issue":"7","key":"2026100513374562700_lvag181-B36","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1210\/clinem\/dgae022","article-title":"Effects of exogenous GIP and GLP-2 on bone turnover in individuals with type 2 diabetes","volume":"109","author":"Skov-Jeppesen","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"2026100513374562700_lvag181-B37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"2026100513374562700_lvag181-B38","doi-asserted-by":"publisher","first-page":"171212","DOI":"10.1016\/j.peptides.2024.171212","article-title":"GIP-derived GIP receptor antagonists\u2014a review of their role in GIP receptor pharmacology","volume":"177","author":"Rosenkilde","year":"2024","journal-title":"Peptides"},{"issue":"1","key":"2026100513374562700_lvag181-B39","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-020-18751-8","article-title":"Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism","volume":"11","author":"Killion","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2026100513374562700_lvag181-B40","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"2026100513374562700_lvag181-B41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1359\/jbmr.071202","article-title":"Impact of glucose-dependent insulinotropic peptide on age-induced bone loss","volume":"23","author":"Ding","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2026100513374562700_lvag181-B42","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1089\/scd.2010.0009","article-title":"Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells","volume":"19","author":"Cramer","year":"2010","journal-title":"Stem Cells Dev"},{"issue":"1","key":"2026100513374562700_lvag181-B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/rej.2006.9.31","article-title":"Glucose-induced replicative senescence in mesenchymal stem cells","volume":"9","author":"Stolzing","year":"2006","journal-title":"Rejuvenation Res"},{"issue":"9","key":"2026100513374562700_lvag181-B44","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss\u2014chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab"},{"issue":"1","key":"2026100513374562700_lvag181-B45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.17925\/EE.2022.18.1.10","article-title":"Tirzepatide: a novel, once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes","volume":"18","author":"Kaneko","year":"2022","journal-title":"touchREV Endocrinol."},{"issue":"16","key":"2026100513374562700_lvag181-B46","doi-asserted-by":"publisher","first-page":"e122219","DOI":"10.1172\/jci.insight.122219","article-title":"Chronic kidney disease attenuates the plasma metabolome response to insulin","volume":"3","author":"Roshanravan","year":"2018","journal-title":"JCI Insight"},{"key":"2026100513374562700_lvag181-B47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag181\/71236177\/lvag181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/549\/71236177\/lvag181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/195\/4\/549\/71236177\/lvag181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:37:53Z","timestamp":1791221873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/195\/4\/549\/8818162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag181","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,19]]}}}